News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sorin Group S.p.A. Announces The Preliminary Results Of A Multicentric Clinical Trial On Freedom Solo(TM)
September 18, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BERLIN--(BUSINESS WIRE)--Sept. 18, 2006-- The Innovative Biological Valve is Rapidly Adopted Thanks to Excellent Haemodynamic Performance, High Biocompatibility and an Easy Implant Procedure
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
May 13, 2026
·
4 min read
·
Nick Paul Taylor
Huntington’s disease
UniQure eyes UK approval for embattled Huntington’s gene therapy after FDA quarrel
April 30, 2026
·
2 min read
·
Heather McKenzie
Company closure
6 biotechs that called it quits in Q1
April 30, 2026
·
6 min read
·
Angela Gabriel
Regulatory
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
April 22, 2026
·
2 min read
·
Tristan Manalac